Merck KGaA

Fitch Revises Merck & Co.'s Ratings Outlook to

Description: Fitch Ratings-Chicago-17 November 2008: Fitch Ratings has affirmed Merck & Co.'s (Merck) ratings, and revised the Rating Outlook to Negative from Stable. The ratings affirmed are: --Long-term Issuer Default Rating...

Immunization - New findings from Merck & Company, Inc. in the area of immunization published

New findings from Merck & Company, Inc. in the area of immunization published According to a study from the United States, "Merck is a global research-driven pharmaceutical company that, throughout its history, has devoted...

Galapagos Extends Collaboration with Merck Serono

GEN News Highlights Galapagos' service division BioFocus will receive Euro 1.1 million ($1.4 million) as the result of a one-year extension of its agreement with Merck Serono. BioFocus will provide SoftFocus compounds for use...

High Growth Reported for the World Pharmaceuticals Market Brief

NEW YORK (Business Wire) -- Punctuated with 18 statistically rich tables, the global market discussion offers special preludes to major market segments, such as, Prescription Drugs, Blockbuster Drugs, Anti-Depressants, COPD,...

Statement by Merck & Co., Inc., in Response to the FDA's Update Regarding a Safety Review on...

FDA announced its update on the safety review of bisphosphonates, including FOSAMAX, that found no clear association between overall bisphosphonate exposure and the rate of serious or non serious atrial fibrillation. Increasing...

NitroMed and Archemix Announce Merger Agreement

NitroMed, Inc. (NASDAQ: NTMD) and Archemix Corp., a privately-held biopharmaceutical company working to develop aptamer-based therapeutics, announced today that they have entered into a definitive merger agreement under which...

Learn about the World Biotechnology Market Brief (Business Wire)

Tuesday November 18, 8:27 am ET NEW YORK--(BUSINESS WIRE)--Reportlinker.com announces that a new market research report related to the Biotechnologies and Genetics industry is available in its catalogue. Market (2003):...

Merck Drug Fails To Slow Alzheimer's Symptoms

An experimental Merck & Co Inc drug that raises levels of a natural growth hormone failed to improve memory skills in people with mild to moderate Alzheimer's disease, U.S. researchers said on Monday. The compound, called...

Four-type HPV Vaccine Gardasil(R) Is Also Effective In Men

The four-type (6,11,16,18) human papillomavirus (HPV) vaccine Gardasil® is also effective in men according to the primary analysis from a pivotal phase III clinical study. In previously uninfected men aged 16 to 26 years*,...

Merck Announces Voluntary Delisting from Philadelphia Stock Exchange

Merck & Co., Inc. announced today the Company's intention to voluntarily delist its common shares from the NASDAQ OMX – PHLX, Inc., formerly the Philadelphia Stock Exchange (PHLX), following a decision by the exchange to...

1 2 3 4 5 next »